Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Cervical cancer worldwide.
Mailinh Vu1, Jim Yu1, Olutosin A Awolude2
1Department of Obstetrics, Gynecology, and Reproductive Biology, Western Connecticut Health Network, Danbury, Connecticut; University of Vermont, Larner College of Medicine, Burlington, Vermont.
Cervical cancer disproportionately affects women in low-resource nations due to limited access to vaccination, screening, and treatment programs. Addressing resource disparities is crucial for global cervical cancer prevention and control.
Area of Science:
- Oncology
- Global Health
- Public Health Policy
Background:
- Cervical cancer ranks as the fourth most common malignancy globally among women.
- Incidence and mortality rates are significantly higher in low- and middle-income countries (LMICs) compared to high-income nations.
Purpose of the Study:
- To highlight the global disparities in cervical cancer burden.
- To underscore the impact of resource availability on cancer prevention and treatment programs.
Main Methods:
- This study is a review of existing literature and global health data.
- Analysis focuses on resource allocation, healthcare infrastructure, and program implementation in different economic settings.
Main Results:
- High-income countries have established vaccination and screening programs, leading to reduced cervical cancer incidence.
- LMICs face significant challenges due to limited resources, hindering the implementation of effective preventative and treatment strategies.
Conclusions:
- Resource disparities are the primary driver of the unequal burden of cervical cancer worldwide.
- Strengthening healthcare infrastructure and resource availability in LMICs is essential to reduce cervical cancer incidence and improve outcomes.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

